Loading...
Loading...
All product recalls associated with Rising Pharma Holding, Inc..
Total Recalls
1000
Past Year
631
Class I (Serious)
65
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Label declares tofu but it does not declare soy.
Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.